Press Releases

CARY, N.C. and BASEL, Switzerland, Sept. 5, 2019 /PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug develop

CAMBRIDGE, Mass., Sept. 5, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of Fred Driscoll to its Board of Directors.  Mr. Driscoll brings to SmartPharm's Bo

LAVAL, QC, Sept. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today a

REHOVOT, Israel, Sept. 5, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that  Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on&nbs

WESTON, Fla., Sept. 5, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company developing first-in-class drugs for inflammatory and renal diseases, is pleased to announce significant advancements in development of our lead inflammasome inhibitor candidate, IC 100.  IC 100 is a novel monoclonal antibody that inhibits the

AUSTIN, Texas, Sept. 5, 2019 /PRNewswire/ -- Superior HealthPlan has made telehealth services available to nearly 1.3 million members who are covered through the health plan statewide. The service will expand access to healthcare for Superior members while removing transportation and geographic barriers to care. "While Superior offers an expansive provider n

BLOOMFIELD, Conn., Sept. 5, 2019 /PRNewswire/ -- Breakthrough, potentially life-changing medicines offer great promise for patients and their families. However, the high prices of the medicines – millions of dollars in some cases – threaten coverage and access by patients who may benefit. Experience the interactive Multichannel News Release here:

COLUMBIA, M.D., Sept. 5, 2019 /PRNewswire/ -- ACell, Inc. today announced the launch of their new product, Gentrix® Hiatal at the 2019 Society of Laparoendoscopic Surgeons (SLS) Minimally Invasive Surgery Week 2019 (MISWeek 2019) in New Orleans, Louisiana. Gentrix Hiatal provides physicians a new solution for hiatal

FOUNTAIN VALLEY, Calif., Sept. 5, 2019 /PRNewswire/ -- Nobles Medical Technologies II has received approval from the U.S. Food and Drug Administration (USFDA) to conduct a prospective pivotal clinical trial called "STITCH" for the expanded indication of PFO Closure for Reduction of Recurrent Ischemic Stroke.

WATERTOWN, Mass., Sept. 5, 2019 /PRNewswire/ -- Liaison International, the leader in admissions management and enrollment marketing solutions for higher education, today provided details about the robust third-cycle growth of BioMedCAS™, the Centralized Application Service (CAS™) for biomedical science programs.